Home › Trials › NCT06218875

Observational registry for patients treated with GORE® endovascular devices for abdominal aortic aneurysms

Assessment of Long Term, Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

W.L.Gore & Associates · NCT06218875

This study is tracking patients who have been treated with GORE® devices for abdominal aortic aneurysms to see how they do over the next 10 years.

Quick facts

Study typeObservational
Enrollment2000 (estimated)
Ages18 Years and up
SexAll
SponsorW.L.Gore & Associates (industry)
Locations90 sites (Little Rock, Arkansas and 89 other locations)
Trial IDNCT06218875 on ClinicalTrials.gov

What this trial studies

This observational registry collects real-world data on patients treated with the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis. The study aims to follow patients for up to 10 years post-procedure to assess outcomes and any issues related to the devices. Patient selection and treatment interventions will be determined by physicians based on standard clinical practice, ensuring that the data reflects routine care. Participants will attend regular follow-up visits and report any concerns to their healthcare providers.

Who should consider this trial

Good fit: Ideal candidates include adults aged 18 and older who are being treated with the GORE® endovascular devices.

Not a fit: Patients who are unlikely to attend follow-up visits or are enrolled in concurrent studies may not benefit from this registry.

Why it matters

Potential benefit: If successful, this registry could provide valuable insights into the long-term effectiveness and safety of GORE® endovascular devices for treating abdominal aortic aneurysms.

How similar studies have performed: Other observational studies have successfully collected real-world data on similar endovascular devices, indicating a precedent for this approach.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

1. Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements
2. Patient has been or is intended to be treated with an eligible registry device
3. Patient is age ≥ 18 years at time of informed consent signature.

Exclusion Criteria:

1. Patient who is, at the time of consent, unlikely to be available for standard of care (SOC) follow-up visits as defined by the site's guidelines and procedures.
2. Patient with exclusion criteria required by local law.
3. Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study within 12 months of Together Registry enrollment. Subjects cannot be enrolled in another Together Registry module protocol.

Where this trial is running

Little Rock, Arkansas and 89 other locations

+40 more sites — see ClinicalTrials.gov for the full list.

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: AAA - Abdominal Aortic Aneurysm, Aneurysm, Aneurysm Repair, Endovascular, EVAR, Endoprosthesis, Aortic, Aortic Repair

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.